13Indexed trials
mesh condition
Heart Diseases
Intelligence
Heart Diseases intelligence: 13 indexed trials, 2 recruiting studies, 13 sponsors across 25 countries.
2Recruiting
13Sponsors
25Countries
Leading sponsors
Columbia University10 recruiting
Duke University10 recruiting
Eidos Therapeutics, a BridgeBio company11 recruiting
Insel Gruppe AG, University Hospital Bern11 recruiting
King's College London10 recruiting
National Heart, Lung, and Blood Institute (NHLBI)10 recruiting
North Essex Partnership NHS Foundation Trust10 recruiting
Oregon Health and Science University10 recruiting
Thomas Jefferson University10 recruiting
University of Calgary10 recruiting
University of Minnesota10 recruiting
University of Texas at Austin10 recruiting
Geographic activity
United States6trials
United Kingdom4trials
Canada2trials
Belgium1trials
Denmark1trials
France1trials
Ireland1trials
Greece1trials
Germany1trials
Italy1trials
Japan1trials
Brazil1trials
Leading interventions
Acoramidis1trials
Conventional pacemaker DDD1trials
Facilitated group-based aerobic dance1trials
Facilitated group-based nutritional intervention1trials
Individual self-paced nutritional intervention1trials
Leadless pacemaker Micra AV1trials
Living with LTC Questionnaire1trials
Mindfulness-Based Stress Reduction (MBSR).1trials
Online, video prompted, individual aerobic dance1trials
Patient Navigator1trials
Placebo Pill.1trials
Placebo oral tablet1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.